Pfizer secures up to $1.5 billion from Blackstone for obesity drug development

Nov 11 (Reuters) – ​Pfizer ‌said on Wednesday ‌Blackstone would ​provide ⁠up ⁠to $1.5 billion ​through ⁠2028 ⁠to help ​fund ​the development ‌of its ⁠experimental monthly obesity ⁠treatment.

(Reporting ‌by ⁠Kunal ​Das ‌in ​Bengaluru; ⁠Editing by Leroy ​Leo)